The emerging role of digital health in the management of asthma.
Journal Information
Full Title: Ther Adv Chronic Dis
Abbreviation: Ther Adv Chronic Dis
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Pharmacology & Pharmacy
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Dr. AK declares that he has received consulting fees from AstraZeneca, Bellus, Covis Pharma, Eisai, GlaxoSmithKline, Pfizer, Merck Frost, Sanofi, Teva, Trudel, and Valeo. He has received honoraria from AstraZeneca, Boehringer Ingelheim, Covis Pharma, Cipla, Eisai, GlaxoSmithKline, Merck Frosst, Novo Nordisk, Moderna, Pfizer, Sanofi, Teva, Trudel, and Valeo. He received a FENO machine from Sanofi as part of a severe asthma survey. Mr. MB declares that he has received honoraria as a speaker and consultant for CHE activities from Pfizer, Novo Nordisk, Khiron, Johnson & Johnson, AbbVie, Teva, Biosyent, Boehringer Ingelheim, Moderna, Canopy, and Valneva. He has also been a consultant for CHE activities on advisory boards for Novo Nordisk, Emergent BioSolutions, Pfizer, and Novamax. Dr. JB declares that he has no competing interests in association with this manuscript. Dr. JK declares that he received grants/contracts from Novo Nordisk. He received consulting fees from Abbott, AbbVie, AstraZeneca, Bayer, BD, Boerhinger Ingelheim, Eisai, Embecta, Eli Lilly, GlaxoSmithKline, Janssen, Novo Nordisk, Miravo Pharm, Teva, Takeda, and Sanofi. He has received honoraria from Abbott, AbbVie, AstraZeneca, Boerhinger Ingelheim, Eisai, Embecta, Eli Lilly, GlaxoSmithKline, Janssen, Novo Nordisk, Miravo Pharm, Moderna, Pfizer Takeda, Sanofi, and Otsuka. Dr. SH declares that he received an honorarium as a workshop facilitator for Teva. Dr. CL declares that his institution has received grants/contracts from AstraZeneca, the Ontario Ministry of Health, Canadian Institutes of Health Research, and the Federal Economic Development Agency for Southern Ontario. His company has received payment/honoraria from AstraZeneca, Boerhinger Ingelheim, Covis Pharma, GlaxoSmithKline, Novartis, and Valeo. He has participated in advisory boards for AstraZeneca, GlaxoSmithKline, Novartis, Sanofi Genzyme, and Teva."
"Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Editorial assistance with the preparation of this manuscript was funded by Teva Canada."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025